Anna Ka Pian (安钠咖片)安钠咖片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 四川锡成药业有限公司Chinese legal name: 四川锡成药业有限公司
主要成分Active Ingredients
- 苯甲酸钠Benjia Suanna
药物知识说明
苯甲酸钠是一种在国家药监局注册认定的药品。该药品含有苯甲酸钠-d31a34ff等成分。
该药品关联的活性成分包括：苯甲酸钠Benjia Suanna。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：四川锡成药业有限公司Chinese legal name: 四川锡成药业有限公司。
您可以探索含有相同成分的其他药品：苯甲酸钠-d31a34ff成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 安钠咖片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 苯甲酸钠Benjia Suanna.
Manufacturers recorded for this product: 四川锡成药业有限公司Chinese legal name: 四川锡成药业有限公司.
Explore other medicines containing the same ingredient: 苯甲酸钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 安钠咖片Recorded Chinese name: 安钠咖片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 苯甲酸钠0.15g;无水咖啡因0.15gRecorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 四川锡成药业有限公司Chinese legal name: 四川锡成药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H51023349
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H51023349
Manufacturer
Chinese legal name: 四川锡成药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H51023349
生产企业
四川锡成药业有限公司(国产)
适应症
中枢神经兴奋药。用于中枢性呼吸及循环功能不全，也可用于麻醉药或催眠药中毒等的昏迷状态。
用法用量
常用量口服 一次―2片，一日2―6片极量，口服一次2片，一日10片。饭后服用，或遵医嘱。
不良反应
1.咖啡因的成人致死量一般为10克，其血药浓度为60～160μg/ml，尿内出现管形或红细胞，有死于肝昏迷的报道。|2.常见的有胃部不适、恶心、呕吐、头痛及失眠等；长期习惯性地过多服用，可出现头痛、紧张、激动和焦虑。
禁忌
胃溃疡患者禁用。
注意事项
1.咖啡因能促进血浆肾素的活性，儿茶酚胺的释放也增多，但破坏亦快，不一定出现血压升高。|2.对前列腺素受体是弱激动强拮抗。|3.能使血糖微升。|4.长期服用大量，有耐受性，也有习惯性。
贮藏
密封，置阴凉处。
规格
苯甲酸钠0.15g;无水咖啡因0.15g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.